Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
996.0000 23.30 (2.40%)
NSE Apr 01, 2026 13:21 PM
Volume: 57,570
 

logo
Alivus Life Sciences Ltd.
27 Jan 2023
996.00
2.40%
buy
by BOB Capital Markets Ltd.
Target: 585
BOB Capital Markets Ltd.
Q3 revenue up 6% QoQ to Rs 5.4bn supported by sequential recovery in API business to parent and PLI benefits
 
Alivus Life Sciences Ltd. is trading above all available SMAs
More from Alivus Life Sciences Ltd.
Recommended
Market trades higher, Ola Electric's registrations soar 150% MoM in March
Trendlyne Marketwatch | 01 Apr 2026, 01:03PM
Five stocks to buy from analysts this week - March 31, 2026
The Baseline | 31 Mar 2026, 06:14PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021